Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reconsolidation Blockade for PTSD in First Responders
NCT03152175Phase 2Unknown
- Sponsor
- Douglas Mental Health University Institute
- Start
- Mar 2017
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of propranolol in post-traumatic stress disorder (PTSD), acute stress disorder (ASD), adjustment disorder (AD), sponsored by Douglas Mental Health University Institute. Status: unknown.
02
Drugs
propranolol
03
Conditions
post-traumatic stress disorder (PTSD)acute stress disorder (ASD)adjustment disorder (AD)
Beyond the preview
Go deeper on NCT03152175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03152175.